GlassScriptPhysician profile
Stephan L Cassidy
NPI 1679630867
$4,557.08
in general payments reported to CMS, 2019-2025
20 companies · $386 in 2025
The $386 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $590 · 2020: $239 · 2021: $528 · 2022: $645 · 2023: $849 · 2024: $1,322 · 2025: $386.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,556.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,556.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $947.60 | 2020-2025 | Dailies Total1, Dailies, Precision7 |
| Bausch & Lomb Americas INC. | $736.91 | 2022-2025 | Miebo, Xiidra, Infuse |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $639.77 | 2019-2021 | |
| Lumenis Be INC | $574.79 | 2024 | Optilight |
| Coopervision INC. | $464.56 | 2019-2025 | Misight Contact Lens, Myday Contact Lens, Paragon Crt |
| Johnson & Johnson Vision Care, INC. | $300.14 | 2019-2023 | Acuvue |
| Novartis Pharmaceuticals Corporation | $201.84 | 2020-2023 | |
| Allergan, INC. | $125.58 | 2020-2022 | |
| Biotissue Holdings INC. | $114.91 | 2019-2025 | |
| Carl Zeiss Meditec USA, INC. | $90.91 | 2024 | Cirrus Hd-Oct |
| Astellas Pharma US INC | $76.42 | 2024 | Izervay |
| Abbvie INC. | $52.84 | 2022 | |
| Oyster Point Pharma, INC. | $49.67 | 2022-2025 | Ryzumvi, Tyrvaya |
| Tarsus Pharmaceuticals, INC. | $42.05 | 2024-2025 | Xdemvy |
| Dompe US, INC. | $33.74 | 2025 | Oxervate |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $33.47 | 2023 | Cequa |
| Mallinckrodt Hospital Products INC. | $22.23 | 2024 | Acthar |
| Sight Sciences, INC. | $17.41 | 2019 | |
| Carl Zeiss Meditec, INC. | $17.24 | 2020 | |
| Maculogix, INC. | $15.00 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephan Cassidy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.